BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 27776290)

  • 1. Good riddance to the term "refractory anemia" in myelodysplastic syndromes.
    Steensma DP
    Leuk Res; 2016 Dec; 51():22-26. PubMed ID: 27776290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors influencing survival in myelodysplastic syndromes in a Brazilian population: comparison of FAB and WHO classifications.
    Lorand-Metze I; Pinheiro MP; Ribeiro E; de Paula EV; Metze K
    Leuk Res; 2004 Jun; 28(6):587-94. PubMed ID: 15120935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Myelodysplastic syndrome classification].
    Ghariani I; Braham N; Hassine M; Kortas M
    Ann Biol Clin (Paris); 2013; 71(2):139-44. PubMed ID: 23587576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Classification and scoring systems in myelodysplastic syndromes: a retrospective analysis of 311 patients.
    Navarro I; Ruiz MA; Cabello A; Collado R; Ferrer R; Hueso J; Martinez J; Miguel A; Orero MT; Pérez P; Nolasco A; Carbonell F
    Leuk Res; 2006 Aug; 30(8):971-7. PubMed ID: 16423393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Historical perspectives on myelodysplastic syndromes.
    Steensma DP
    Leuk Res; 2012 Dec; 36(12):1441-52. PubMed ID: 22921019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The myelodysplastic syndromes: a personal recollection of four decades of classification and prognostic scoring systems.
    Bennett JM
    Leuk Lymphoma; 2013 Dec; 54(12):2588-91. PubMed ID: 23547832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in the distribution of subtypes according to the WHO classification 2008 between Japanese and German patients with refractory anemia according to the FAB classification in myelodysplastic syndromes.
    Matsuda A; Germing U; Jinnai I; Araseki K; Kuendgen A; Strupp C; Iwanaga M; Miyazaki Y; Hata T; Bessho M; Gattermann N; Tomonaga M
    Leuk Res; 2010 Aug; 34(8):974-80. PubMed ID: 20022110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The myelodysplastic syndromes: towards a functional classification.
    Mijović A; Mufti GJ
    Blood Rev; 1998 Jun; 12(2):73-83. PubMed ID: 9661795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Refractory anemia (RA) and refractory cytopenia with multilineage dysplasia (RCMD) in WHO classification: comparison between Japanese and German cases].
    Matsuda A; Germing U
    Rinsho Ketsueki; 2004 Apr; 45(4):268-73. PubMed ID: 15168441
    [No Abstract]   [Full Text] [Related]  

  • 10. [Myelodysplastic syndromes--from FAB to WHO classification].
    Kotlarek-Haus S; Haus O
    Pol Arch Med Wewn; 2005 Nov; 114(5):1128-37. PubMed ID: 16789514
    [No Abstract]   [Full Text] [Related]  

  • 11. Difference in clinical features between Japanese and German patients with refractory anemia in myelodysplastic syndromes.
    Matsuda A; Germing U; Jinnai I; Misumi M; Kuendgen A; Knipp S; Aivado M; Iwanaga M; Miyazaki Y; Tsushima H; Sakai M; Bessho M; Tomonaga M
    Blood; 2005 Oct; 106(8):2633-40. PubMed ID: 15972453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Refractory anemia and the myelodysplastic syndromes.
    Lawrence LW
    Clin Lab Sci; 2004; 17(3):178-86. PubMed ID: 15314893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Myelodysplastic syndrome].
    Urabe A
    Gan To Kagaku Ryoho; 2005 Mar; 32(3):287-91. PubMed ID: 15791810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparative review of classification systems in myelodysplastic syndromes (MDS).
    Bennett JM
    Semin Oncol; 2005 Aug; 32(4 Suppl 5):S3-10. PubMed ID: 16085011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The myelodysplastic syndromes.
    Masey JA
    Br J Biomed Sci; 1997 Mar; 54(1):65-70. PubMed ID: 9167309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective validation of the WHO proposals for the classification of myelodysplastic syndromes.
    Germing U; Strupp C; Kuendgen A; Isa S; Knipp S; Hildebrandt B; Giagounidis A; Aul C; Gattermann N; Haas R
    Haematologica; 2006 Dec; 91(12):1596-604. PubMed ID: 17145595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Refractory cytopenia with multilineage dysplasia: further characterization of an 'unclassifiable' myelodysplastic syndrome.
    Rosati S; Mick R; Xu F; Stonys E; Le Beau MM; Larson R; Vardiman JW
    Leukemia; 1996 Jan; 10(1):20-6. PubMed ID: 8558932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A retrospective analysis of myelodysplastic syndromes with thrombocytosis: reclassification of the cases by WHO proposals.
    Cabello AI; Collado R; Ruiz MA; Martínez J; Navarro I; Ferrer R; Sosa AM; Carbonell F
    Leuk Res; 2005 Apr; 29(4):365-70. PubMed ID: 15725469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Refractory anemia.
    Uchino H
    Nihon Ketsueki Gakkai Zasshi; 1986 Dec; 49(8):1536-45. PubMed ID: 3551437
    [No Abstract]   [Full Text] [Related]  

  • 20. The classification of MDS: from FAB to WHO and beyond.
    Vardiman J
    Leuk Res; 2012 Dec; 36(12):1453-8. PubMed ID: 22940257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.